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Abstract: 
Oceanic cyanobacteria are the most abundant oxygen-generating phototrophs on our planet, and 
therefore, important to life. These organisms are infected by viruses called cyanophages, recently 
shown to encode metabolic genes that modulate host photosynthesis, phosphorus cycling and 
nucleotide metabolism. Herein, we report the characterisation of a wild type flavin-dependent viral 25 
halogenase (VirX1) from a cyanophage. Notably, halogenases have been previously associated 
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with secondary metabolism, tailoring natural products. Exploration of this viral halogenase reveals 
it capable of regioselective halogenation of a diverse range of substrates, with a preference for 
forming aryl iodide species; this has potential implications for the metabolism of the infected host. 
Until recently, a flavin-dependent halogenase (FDH) capable of iodination in vitro had not been 
reported. VirX1 is interesting from a biocatalytic perspective showing strikingly broad substrate 5 
flexibility, and a clear preference for iodination, as illustrated by kinetic analysis. These factors 
together render it an attractive tool for synthesis. 
 
 
 10 
 
 
The selective formation of carbon-halogen (C-X) bonds is of great importance to the 
pharmaceutical and agrochemical industries1,2. The introduction of a halogen (X) into a molecule 
can be used to modulate bioactivity, bioavailability and metabolic stability1-3. Traditional chemical 15 
methodologies of halogenating aromatic substrates generally employ highly reactive reagents and 
generate harmful waste. As traditional reagents lack components that enable the tuning of product 
selectivity, they oftentimes generate products in which either only the most nucleophilic position 
is halogenated or mixtures of products are produced. Conversely, biosynthetic (enzymatic) 
halogenation is mild, highly selective and utilises simple salts such as NaCl or NH4Br as the source 20 
of halide while oxygen serves as the oxidant1-3. Consequently, the discovery and structural 
characterisation of flavin-dependent halogenases (FDHs) capable of selectively forming C-Cl and 
C-Br bonds4,5 and the discovery of a S-adenosylmethionine (SAM)-dependent fluorinase6, able to 
mediate nucleophilic C-F bond formation, attracted considerable attention. Until recently, a FDH 
capable of generating C-I bonds remained to be discovered and characterised7.  25 
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The FDHs that have previously been studied are predominantly drawn from a limited number of 
well-known phyla2,3,7,8. It may be seen, through branching analysis of protein sequences, that 
correlation exists between protein sequence and substrate preference. Such preference includes the 
presentation of the substrate i.e. whether or not it is covalently tethered to an associated enzyme 
(Fig. 1). Almost all previously discovered FDHs have been determined due to their role in the 5 
generation of halogenated natural products2-9. Many of these metabolites arise from well-studied 
bacteria, especially actinomycetes, or from fungi. As halogenases only from a very limited series 
of organisms have been explored, so far, their natural substrate specificity has been limited. 
Significant effort has been invested into the rational redesign and directed evolution of these 
enzymes in order to expand or change the substrate specificity10-14. 10 
  
Results and discussion: 
Bioinformatics-based discovery of VirX1. Breaking from this trend in halometabolite-led 
identification of enzymes, we adopted a bioinformatics-based approach. Compiling data from all 
fully biochemically and structurally characterised FDH enzymes, sequence alignment enabled us 15 
to see both the known GxGxxG and WxWxIP motifs4, as well as a previously unnoticed motif 
Fx.Px.Sx.G15. Whilst GxGxxG and WxWxIP motifs have hitherto been utilized to indicate the 
presence of FDHs, GxGxxG could as readily indicate flavin monooxygenases (FMOs) related 
enzymes and the WxWxIP motif is known to be absent in more unusual FDHs, such as Bmp516. 
The Fx.Px.Sx.G motif [where x is any amino acid and each (.) represents independently the number 20 
of x between each conserved residue and can be any number: 0, 1, 2 etc.] may be utilized, by itself, 
to mine for halogenases from uncurated genome sequences15.  
Using our motif as a probe, we revealed the presence of an open reading frame (ORF), deposited 
as “hypothetical protein CPUG_00131” within the cyanophage Syn10, a broad host range 
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cyanophage with a 177 kbp genome known to infect Prochlorococcus and Synechococcus17. We 
named the encoded protein as “VirX1”. Aligned against known halogenases, VirX1 shows low 
similarity to PrnA and RebH (29% and 31% respectively), the well-studied tryptophan 7-
halogenases. It may therefore be classified as being in the “Twilight Zone” of sequence similarity18. 
Generation of a homology structural model of VirX1 using Phyre219 and comparative analysis of 5 
this to PrnA and all other structurally characterised halogenases revealed the characteristic 
structure of tryptophan halogenases with the pyramid and box shape4. However, the model of 
VirX1 indicated the presence of a higher number of loops within the C-terminal domain of VirX1, 
potentially enabling larger conformational changes upon substrate binding and enhanced substrate 
specificity compared to typical tryptophan halogenases. The active site could be identified from 10 
the position of the Fx.Px.Sx.G motif, as well as the co-factor binding site GxGxxG.  
 
Iodination activity, substrate scope and kinetics of VirX1. We set out to explore whether the 
encoded protein was indeed an active halogenase, and if so, whether it might show useful 
biocatalytic utility including substrate flexibility. To this end we screened the halogenase against 15 
a 400-member library containing substrates that would sterically and electronically challenge the 
potential catalyst, using LC-HRMS and UPLC to validate the generation of new, halogenated 
products. Under the conditions of our assay, the enzyme showed very poor activity in chlorinating 
substrates, but good bromination activity and a surprising preference for iodination. The wild type 
enzyme demonstrated striking substrate flexibility (Fig. 2). From this 400-member library, it was 20 
determined that 32 sterically and electronically diverse compounds could be accepted as substrates, 
with 1-95% conversion (Fig. 2). For each substrate that was processed, LC-HRMS analysis 
indicated that, biotransformative halogenation resulted in the formation of monoiodinated product 
only. For the majority of substrates only a single regioisomer was observed. Enzymatic 
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halogenation could be seen to be mediated on several less reactive or challenging substrates, 
including (poly)heterocycles (5)20, azaspirocycles (14)21 or bathophenanthroline (30), that were not 
readily iodinated using synthetic conditions at room temperature. Fourteen of these products were 
selected, based on both structural interest and conversion level, for further analysis including 
spectroscopic structural characterisation. This analysis revealed that although halogenation often 5 
was mediated at the most chemically reactive position, this was not always the case. For example, 
enzymatic products 3, 5, 7, 8, 12 and 14 did not match with synthetic iodo-standards prepared via 
electrophilic iodination, indicating the possibility of different regioisomers being formed (Fig. 2). 
Steady state kinetic analysis of the enzyme catalysed reaction was carried out for twelve of these 
substrates (Table 1).  10 
 
Kinetic analysis revealed the enzyme to have preference for iodide over bromide (Table 1). This 
is unprecedented as there has been no previous characterisation of FDHs with a clear natural 
preference for iodination in vitro. Previous reports exploring whether RebH might mediate 
iodination, revealed in halide competition assays, that the introduction of NaI prevented the 15 
formation of any chlorinated product, and yet no iodinated product was observed22. Conversely, in 
the competition assays that we explored with VirX1 using equivalent concentrations of NaI, NaBr 
and NaCl, only the iodinated product could be detected (Supplementary Fig. 17). Under the 
conditions of our assay, and with all substrates explored, the preference for the halide, shown by 
VirX1, is I > Br > Cl corresponding to the decreasing oxidative potential of the halide. 20 
Recently the PltM halogenase7 has been reported to be flexible in terms of halide-versatility, 
permissibly enabling iodination of phenolic substrates. Spectroscopic characterisation of the 
iodinated compounds produced by PltM was not reported, (possibly due to the notorious instability 
of iodinated compounds precluding isolation), nor were any kinetics reported for the reaction, as 
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the enzyme was seen to precipitate in the presence of NaI, indicating poor tolerance to this halide19. 
This versatility of halide utilisation observed for PltM, in which iodination is permissible, is 
perhaps more extensive. In this study, we showed that though PrnA could not iodinate its natural 
substrate tryptophan, excitingly with a number of its unnatural substrates, discernible levels of 
iodination were evident, though typically at ~1% conversion (Supplementary Table 6). We 5 
explored whether PrnA might also mediate halogenation of substrates that are processed by VirX1. 
We saw that PrnA could indeed process many of the substrates, to a low level. It may be that many 
of the FDHs, in addition to PrnA and PltM, could be capable of very limited /trace iodination in 
the presence of certain substrates.  
VirX1 however shows very clear iodination activity. Specifically, iodination by VirX1 of a 10 
modest/non-native substrate 6-azaindole (1) proceeds with a kcat of 5 min-1 (kcat/Km of 0.18 min-1 
µM-1) whilst PrnA’s chlorination of its natural substrate progresses more slowly with a kcat of 0.093 
min-1 (kcat/Km of 0.0006  min-1 µM-1)4. Synthetic halogenation of 6-azaindole (1) with free 
hypohalous acid, at low concentration in phosphate buffer, unsurprisingly results in generation of 
di-iodinated species and series of other products, e.g. dimer of bromo-6-azaindole as observed by 15 
LCMS, conversely the enzyme yields only the monoiodinated product and monobrominated as a 
single regioisomer (Supplementary Scheme 1).  
 
Structure of VirX1. We next sought to structurally investigate VirX1. Purification of the protein 
enabled X-ray crystallographic analysis of the apo structure revealing six monomers of VirX1 in 20 
the asymmetric unit (Fig. 3a); all showing highest structural similarity to the PrnA E450K structure 
(DALI search; highest z-score: 47.1, Protein data bank (PDB) ID: 4Z43) sharing box and pyramid 
architecture; agreeing with our bioinformatics predictions4,23. The six monomers in the asymmetric 
unit are predicted by jsPISA 2.0.524 to form two stable trimeric assemblies (Fig. 3b; DGdiss. ~ 42.6 
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kcal mol-1) with protein-protein interfaces covering an area of 10,486.4 Å2 per trimer (Fig. 3). The 
trimeric state of VirX1 was confirmed by analytical size exclusion chromatography revealing an 
apparent molecular weight of VirX1 of ~ 180 kDa in solution, as well as by SEC MALS 
(Supplementary Fig. 13 & Supplementary Table 4) and analytical ultracentrifugation 
(Supplementary Fig. 14 & Supplementary Table 5). The trimer forms a ‘bowl shaped’ assembly 5 
with one substrate binding site per monomer flanking the insides of the bowl (Fig. 3c and 3d). 
The VirX1 structure shows many similarities to other FDHs with the box shaped flavin binding 
module, required for flavin binding and generation of the hypohalous acid electrophile, being 
almost identically folded (Fig. 4a). Both K79 and E358, implicated in halo-amine formation and 
in deprotonation of the Wheland intermediate, respectively, occupy similar positions to K79 and 10 
E346 in the active site of PrnA (Fig. 4b). The positioning of F99 and Y97 is similar to that seen 
for F103 and H101, in PrnA complexing tryptophan (Trp), Cl, flavin adenine dinucleotide (FAD) 
(PDB ID: 2AQJ) that are believed to stabilise the Wheland intermediate4. Assay with 
monochlorodimedone (MCD)4 indicated that the halogenating species must be enzyme bound 
(Supplementary Fig. 18, 19). Site directed mutagenesis was carried out to identify key catalytic 15 
residues, and whilst the mutants K79A, K79R, F353A, S359A and P356A all yielded soluble 
protein, which eluted in a very similar manner to wild type VirX1 suggesting correct folding of 
these mutants; however, each of these mutants were determined to be completely inactive in 
catalysing halogenation of 6-azaindole (1) with either NaI or NaBr, reinforcing the importance of 
these residues for the enzyme’s catalytic activity (Supplementary Fig. 16). 20 
 
As anticipated, with all key catalytic residues in place, the α-helical pyramid-shaped substrate 
module displays a different arrangement of secondary structure elements to its closest structural 
homologue PrnA (Fig. 4a). Key differences include the absence of the α-helical lid required for 
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tryptophan halogenases (T435-W455 in PrnA) closing off the tryptophan binding site (as seen in 
BrvH)25 (Fig. 4c). The substrate binding site of VirX1 displays an even wider opening than BrvH, 
providing a possible explanation for the wide substrate scope, and the ability to accommodate a 
halide with a larger van der Waals radius (Fig. 4c). Additional expansion of the putative substrate 
binding site is enabled by the increased distance of α17 and α18 from the catalytic residues within 5 
it. A further, key difference to PrnA, RebH and BrvH is an additional loop (P432-Q442) taking 
part in the trimer interface through a H-bonding network (Fig. 3b), opening up access to the 
substrate binding site (Fig. 4).  
 
To further explore the VirX1 substrate binding mode, many attempts were made to crystallise 10 
VirX1 in complex with various substrates. However, these did not yield sufficiently diffracting 
crystals for structural analysis, therefore in silico methods were explored instead. Given the 
subjectivity of in silico small molecule protein docking experiments, several complementary 
approaches were explored, with both rigid and flexible models of VirX1. Compounds 1 - 14 were 
docked within a 47.25 × 47.25 × 47.25 Å (105,488 Å3) search space centered on rigid VirX1 (chain 15 
a), which identified a substrate binding cleft in similar position to other FDHs harbouring K79 and 
E358. These results informed further docking experiments restricted to this cleft, conducted with 
rigid and flexible amino acid residues. The flexible docking experiments yielded conformations 
with a decreased binding energy (~ 5 kcal mol-1) for all substrates compared with docking into the 
rigid VirX1 pocket (Supplementary Table 2). The choice of hypothetical binding modes 20 
(Supplementary Fig. 1 - 11) was mainly informed by proximity of the putatively halogenated 
carbon to K79 that would form and position the iodamine for reaction with the substrate and E358 
which would stabilise the Wheland intermediate. Through this analysis, three residues were 
identified to be involved in substrate binding across all docked substrates: Y97, P98 and F99, with 
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the two aromatic resides often seen to be sandwiching the substrate (Supplementary Fig. 1 - 12). 
Other residues such as L53, I82 and G100 were also frequently implicated in binding the docked 
compounds, with the predicted binding mainly comprising of hydrophobic contacts 
(Supplementary Fig. 1 – 12). The docking experiments support binding in a cleft with access to 
K79 and E358, similarly to characterised complex structures of FDH-substrate complexes4. 5 
Several further residues implicated in binding reinforced the extensive active site cavity enabling 
the strikingly broad substrate flexibility (Supplementary Fig. 12). It is likely that oxidation 
potential dictates the preference for halide utilization (as indicated by I > Br > Cl) and that it is 
this enlarged cavity that enables halogenation via a bulky iodamine species. 
 10 
Conclusions: 
Our results reveal catalytically notable, regioselective halogenation by an FDH, with a viral 
derived enzyme demonstrating a preference for iodination. Notably, we also show that by 
extending the substrate scope of PrnA, iodination within this system may also be permissible. We 
demonstrate that VirX1 possesses a very broad substrate flexibility and is able to process sterically 15 
and electronically demanding substrates in addition to series of N and O heterocycles. This may 
be attributed the relatively large and accessible active site revealed by the crystal structure, and the 
high level of conformational flexibility predicted by our modelling studies. Excitingly we reveal a 
system that may be utilised as a biocatalytic tool enabling enzyme catalysed iodination, selective 
C-H activation and the generation of highly reactive species that could be utilised for further 20 
functionalisation.  It is envisioned to be a potentially very powerful tool for enabling modification 
of natural products in the presence of the living host organism, through a living GenoChemetics 
approach26. 
  
10 
 
The role that marine viruses play in manipulating the metabolism of the cyanobacteria they infect 
has recently been postulated27, and therefore, the discovery of an efficient viral halogenase and 
with broad substrate flexibility is interesting. Halogenation of a molecule can significantly perturb 
its bioactivity and bioavailability, and iodination can render a molecule highly chemically reactive. 
Though the levels of iodide in the oceans are very low compared to those for bromide and chloride 5 
(0.05 ppm vs. 65 ppm, and 18980 ppm), marine algae and bacteria have been shown to accumulate 
and utilise iodide28,29. The naturally broad substrate specificity of this enzyme, encoded in a virus 
which naturally infects the two most abundant photosynthetic organisms on the planet, is 
fascinating, and leads one to wonder as to what its natural role might be. We are taking steps to 
explore the impact of this iodinase upon cyanobacterial metabolism. 10 
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Fig. 1: Protein based branching analysis of VirX1 against known FDHs and other non-FDH 
flavoenzymes, revealing functional relationship, known substrate utilisation and branching 
order between protein clusters. VirX1, the viral iodinase (highlighted in purple with arrow), is 
predicted to branch away from the tryptophan chlorinases and brominases, while still being 
associated with their cluster. Analysis highlights the evolved differences in halide preference and 5 
correspondingly grouped substrate preferences of these FDHs. The diagram is represented as an 
unrooted circular phylogram in which nodes (shown as coloured circles) represent each individual 
amino acid sequence analysed and branches (the lines connecting them) represent the degree of 
evolutionary divergence (e.g. number of amino acid substitutions, deletions or insertions that have 
occurred between connected branch points). A global alignment of the full-length amino acid 10 
sequences of VirX1 with other known FDHs and non-FDH flavoenzymes (used as an outgroup) 
was used to construct the branching diagram (through application of neighbor joining method) 
applying the Kimura algorithm for protein distance measurements. Bootstrapping analysis was 
performed in 100 replicates.  
 15 
Fig. 2. Diverse substrate scope of VirX1. Biocatalytic halogenation using VirX1 of a 400-
member compound library revealed 32 compounds as being accepted as substrates. The enzyme is 
shown to monohalogenate a diverse range of sterically and electronically different substrates. 
Fourteen substrates were selected (boxed), based on both interest in the product and their stability, 
for further verification through either scale up and spectroscopic characterisation of their product, 20 
or through comparison to synthetic standards that we generated and fully characterised. Iodinated 
products 1 and 2 were isolated from VirX1 biotransformations, whereas the regiochemistry for 3 
- 14 was determined by comparison with synthetic standards, * denotes hypothesised halogenation 
site by VirX1 where the enzymatic product did not match with synthetic standards. Conversion 
levels, to the iodinated product, as estimated by LC-HRMS or UPLC analysis, are reported. 25 
 
Fig. 3: Crystal structure and homo-trimer assembly of VirX1. a, The content of asymmetric 
unit of VirX1 X-ray crystal structure (2.75 Å; PDB ID: 6QGM) shown in surface representation 
arranged as a dimer of a trimer. Chains a, b, and c are coloured in dark violet, light violet and light 
grey, respectively; and a second trimer is coloured white. b, Bottom view of trimeric VirX1, 30 
highlighting the entanglement of the VirX1 homo-trimer interface. c, Angled top view (sliced) 
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revealing a bowl-shaped topology of VirX1 homo-trimer. d, VirX1 trimer with substrate 14 
(spheres; carbon yellow, nitrogen blue and oxygen red) docked to all three substrate binding sites, 
highlighting a large and buried substrate binding site. 
 
Fig. 4: Structural comparison of VirX1 to the flavin dependent halogenases PrnA (2AQJ) 5 
and BrvH (6FRL). a, Structural alignment (r.m.s.d. 1.166 Å) of VirX1 monomer in dark violet 
and the PrnA complex structure (2AQJ) in light grey, both represented as cartoons. PrnA ligands 
(FAD, Trp and Cl) are represented as spheres. b, View of ligand binding sites in VirX1 zoom into 
the substrate and halogen binding site. Residue side chains, FAD and Trp are represented in ball 
and stick form. c, Surface representation of VirX1 (first panel; dark violet) emphasizing large 10 
substrate binding cleft of VirX1 in comparison to  2AQJ and 6FRL in surface (second panel; light 
grey and dark grey, respectively) and cartoon style (third panel; same colouring as in second 
panel), including Trp (represented as spheres), revealing increased accessibility of VirX1 substrate 
binding cleft compared to PrnA and BrvH. In all panels: ligand carbons, nitrogen, oxygen, 
phosphorus and chlorine atoms are coloured golden, blue, red, orange and green respectively. In 15 
all panels: carbons within proteins are coloured according to backbone colour of respective 
macromolecule. 
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Table 1. Kinetic parameters for iodination and bromination reactions catalyzed by VirX1 
with selected substrates. The values for iodination (light purple columns) and bromination (light 
orange columns) reactions were determined by non-linear regression using Origin. All assays were 
performed in 200 μl total volume containing VirX1 (1 μΜ), an excess of the partner flavin 
reductase PrnF (10 μM), NADH (2.5 mM), NaBr/NaI (10 mM), FAD (10 μΜ) in phosphate buffer 5 
(50 mM, pH 7.4) and varied concentrations of substrate resuspended in DMSO and incubated at 
28 °C. ND denotes not determined. 
 
 
Compound 
NaI NaBr 
kcat 
(min-1) 
Km 
(μΜ) 
kcat/Km 
(min-1 μΜ) 
kcat  
(min-1) 
Km 
(μΜ) 
kcat/Km 
(min-1 μΜ) 
1 5.0 ± 0.5 28 ± 2 0.179 ± 0.004 2.4 ± 0.6 53 ± 3 0.044 ± 0.008 
2 3.1 ± 0.5 145 ± 9 0.021 ± 0.004 1.0 ± 0.1 201 ± 6 0.004 ± 0.001 
3 1.3 ± 0.2 190 ± 6 0.006 ± 0.001 ND ND ND 
4 4.4 ± 0.2 23 ± 2 0.193 ± 0.003 2.9 ± 0.5 31 ± 4 0.093 ± 0.002 
5 3.3 ± 0.1 35 ± 1 0.094 ± 0.002 2.2 ± 0.2 33 ± 9 0.066 ± 0.004 
6 3.5 ± 0.3 241 ± 4 0.014 ± 0.003 1.9 ± 0.1 310 ± 9 0.006 ± 0.001 
7 1.5 ± 0.1 157 ± 3 0.009 ± 0.002 1.7 ± 0.2 227 ± 4 0.007 ± 0.003 
8 3.0 ± 0.1 258 ± 7 0.011 ± 0.001 2.2 ± 0.2 254 ± 2 0.008 ± 0.002 
10 3.4 ± 0.2 238 ± 13 0.014 ± 0.006 2.1 ± 0.3 282 ± 2 0.007 ± 0.003 
11 1.6 ± 0.2 181 ± 6 0.008 ± 0.002 ND ND ND 
12 2.9 ± 0.3 338 ± 18 0.008 ± 0.002 ND ND ND 
14 2.2 ± 0.4 135 ± 12 0.016 ± 0.005 1.4 ± 0.1 240 ± 11 0.005 ± 0.001 
 
